On Monday, Aptevo Therapeutics Inc (NASDAQ: APVO) opened lower -7.96% from the last session, before settling in for the closing price of $1.13. Price fluctuations for APVO have ranged from $1.04 to $118.98 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 80.96%. Company’s average yearly earnings per share was noted 99.69% at the time writing. With a float of $16.84 million, this company’s outstanding shares have now reached $16.85 million.
Aptevo Therapeutics Inc (APVO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Aptevo Therapeutics Inc is 0.08%, while institutional ownership is 7.19%. The most recent insider transaction that took place on Nov 10 ’25, was worth 20,134. In this transaction Director of this company bought 13,513 shares at a rate of $1.49, taking the stock ownership to the 13,514 shares.
Aptevo Therapeutics Inc (APVO) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -178.8 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -155) by -23.8.
According to the Wall Street analysts, stocks earnings will be around 99.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 90.39% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Check out the current performance indicators for Aptevo Therapeutics Inc (APVO). In the past quarter, the stock posted a quick ratio of 4.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -185.07, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Looking closely at Aptevo Therapeutics Inc (NASDAQ: APVO), its last 5-days average volume was 2.65 million, which is a jump from its year-to-date volume of 2.28 million. As of the previous 9 days, the stock’s Stochastic %D was 17.33%.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 1.54%, which indicates a significant decrease from 8.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0942 in the past 14 days, which was lower than the 0.1404 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4160, while its 200-day Moving Average is $9.0816. However, in the short run, Aptevo Therapeutics Inc’s stock first resistance to watch stands at $1.0850. Second resistance stands at $1.1300. The third major resistance level sits at $1.1700. If the price goes on to break the first support level at $1.0000, it is likely to go to the next support level at $0.9600. Now, if the price goes above the second support level, the third support stands at $0.9150.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
There are currently 16,850K shares outstanding in the company with a market cap of 17.52 million. Presently, the company’s annual sales total 0 K according to its annual income of -24,130 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,550 K.
